@VraserX: I don’t think unequal access justifies abandoning life-extension research. I’d rather fight to make a real treatment af…
Summary
A tweet argues that unequal access to life-extension treatments should not justify abandoning research; instead, efforts should focus on making treatments affordable to avoid only the rich benefiting.
View Cached Full Text
Cached at: 09/16/26, 05:58 AM
I don’t think unequal access justifies abandoning life-extension research.
I’d rather fight to make a real treatment affordable than guarantee that nobody gets one. The rich getting longer lives first would be infuriating. Everyone continuing to age would not fix that.
Similar Articles
@VraserX: The comfortable position is to demand we slow AI down. You get to sound responsible while someone else pays the price i…
A tweet argues that calling for a slowdown in AI development is a convenient position that ignores the costs to scientific progress, such as delayed cancer treatments and drug discovery.
@VraserX: We should never slow AI down to appease people who treat every breakthrough as the apocalypse. We should accelerate har…
A tweet arguing against slowing AI development due to fearmongering by 'doomers', advocating for acceleration instead.
@RuxandraTeslo: We are on the cusp of a wave of new therapies for some of the worst diseases. But the world won’t benefit unless the US…
This essay argues that slow and costly U.S. clinical trials—not scientific limitations—are now the biggest obstacle to curing cancer and deploying AI-driven personalized therapies, urging regulatory reform as China and Australia outpace American drug development.
@VraserX: If AI gives everyone access to genius level help, does society become more equal, or do the most ambitious people just …
A Twitter user ponders whether AI's democratization of genius-level help will increase equality or allow the ambitious to pull further ahead.
@VraserX: I can accept that some AI capabilities need restrictions. But if the public gets weaker models while corporations and g…
The tweet argues that AI restrictions should not result in the public receiving weaker models while corporations and governments access powerful ones, calling for better explanations beyond safety and highlighting the political nature of access.